Counseling for smoking cessation among healthcare professionals
Official title: Prospective Study Aimed at Evaluating the Effect of a Counseling Consultation in the Workplace for Smoker Employees in a Mental Health Establishment
Run by Groupe Hospitalier Mutualiste de Grenoble · NCT06988644 · Data updated 2026-11-12
This study tests if counseling at work can help healthcare professionals who smoke quit by measuring their carbon monoxide levels.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Groupe Hospitalier Mutualiste de Grenoble Academic / other |
| Locations | 1 site (Grenoble, isere) |
| Status | Recruiting |
| Started | November 11, 2024 |
| Main results expected | November 30, 2026 |
| Study ends | November 30, 2026 |
| Registry record updated | May 29, 2025 |
| Trial ID | NCT06988644 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are health professionals aged 18 and older who smoke daily and are willing to quit.
✕Probably not a fit
Patients who smoke occasionally or exclusively use vaporizers will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study aims to evaluate the impact of a counseling consultation in the workplace specifically designed for health professionals who smoke. It focuses on measuring exhaled carbon monoxide levels to assess smoking habits and support cessation efforts. The study highlights the prevalence of smoking among healthcare workers and the need for targeted interventions to improve their health and, consequently, patient care. By addressing smoking in this population, the study seeks to reduce the stigma and misconceptions surrounding smoking in healthcare settings.
Why it matters
Potential benefit: If successful, this intervention could significantly improve smoking cessation rates among healthcare professionals, leading to better health outcomes for both the professionals and their patients.
How similar studies have gone: While there is limited data on smoking cessation specifically among healthcare professionals, similar interventions in other populations have shown promising results.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age ≥ 18 years 2. Health professional 3. Daily smoker of at least 1 cigarette or joint per day and every day 4. Willingness to quit smoking 5. Patient physically able and willing to undertake a carbon monoxyde measurement 6. Patient affiliated to a social security scheme or beneficiary of such a scheme 7. Signature of informed consent Exclusion Criteria: 1. Smoking via vaporizer exclusively 2. Occasional (i.e. not daily) smoker or exhaled carbon monoxyde at inclusion \< 9 ppm 3. Resignation, transfer or end of employment contract during the study period (1 year) 4. Unable to undergo study follow-up for geographical, social or psychological reasons 5. Persons under legal protection or unable to express their consent.
Where it's running
-
Groupe Hospitalier Mutualiste Grenoble
Grenoble, isere, France Recruiting
Study contacts
- Study coordinator: Estelle Cotte-Raffour, Nursery
- Email: estelle.cotte-raffour@avec.fr
- Phone: 0033 476708995
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Quitting Matters: a smoking quit program for people living with HIV
This 6-month program will test whether a tailored smartphone app plus nicotine patches and gum helps people living with HIV quit smoking better than a standard quit app.
-
Smoky Futures: Danish Adolescent Nicotine Use over Time
This observational cohort follows Danish youths ages 15–25 to see how cigarette, e-cigarette, and other nicotine use begin, change, and affect health and education over several years.
-
Nicotine Orodispersible Tablet to Relieve Cravings in Smokers
A nicotine mint orodispersible tablet is tested vs placebo to see if it quickly eases the urge to smoke in adult cigarette smokers.
-
Optimizing when weekly chatbot reminders go out to people using a chatbot for quitting smoking
This study tests whether sending weekly reminders at different times helps people stay engaged with a chatbot smoking-cessation service.
-
NMDA and Sigma-1 combination therapy for smoking cessation with AXS-05
This phase 3 trial tests whether AXS-05 can help adults quit smoking better than placebo or bupropion.
-
AI-assisted interactive case-based training to improve smoking cessation counseling by medical interns
This study tests whether AI-powered interactive case-based training helps medical interns provide better smoking cessation counseling.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.